中国标准化Issue(24)：290-293,4.DOI:10.3969/j.issn.1002-5944.2023.24.063
标准化脑膜中动脉栓塞治疗高危复发性慢性硬膜下血肿疗效观察
Efficacy Observation of Standardized Middle Meningeal Artery Embolization for High-risk Recurrent Chronic Subdural Hematoma
摘要
Abstract
Objective:To observe and analyze the efficacy of middle meningeal artery embolization in the treatment of high-risk recurrent chronic subdural hematoma,and analyze its safety.Methods:A retrospective analysis was performed on 23 patients with chronic subdural hematoma who were treated by middle meningeal artery embolization in Three Gorges Hospital Affiliated to Chongqing University from March 2020 to March 2022,including 20 patients with unilateral recurrent chronic subdural hematoma and 3 patients with bilateral recurrent chronic subdural hematoma.The blood recurrence and progression of patients at 1 month,3 months and 6 months after middle meningeal artery embolization were analyzed.The efficacy,outcome and safety of the treatment were analyzed.Results:The recurrence rate of the observation group after treatment was 0,which was significantly lower than that of the control group by 25.00％,with statistical significance(P＜0.05).There was no significant difference in treatment efficiency between the two groups(P＞0.05).Conclusion:Middle meningeal artery embolization can significantly improve the therapeutic effect of chronic subdural hematoma and reduce the recurrence rate,which is worthy of further clinical study.关键词
慢性硬脑膜下血肿/脑膜中动脉栓塞/治疗效果Key words
chronic subdural hematoma/middle meningeal artery embolism/therapeutic effect引用本文复制引用
谭云,宋毅,吴瑶,刘明冬..标准化脑膜中动脉栓塞治疗高危复发性慢性硬膜下血肿疗效观察[J].中国标准化,2023,(24):290-293,4.基金项目
本文受重庆市万州区科卫联合医学科研项目"脑膜中动脉栓塞与阿托伐他汀治疗慢性硬膜下血肿效果对比研究"(项目编号:wzstc-kw2020027)资助. （项目编号:wzstc-kw2020027）
